Wordt geladen...
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
We evaluated the safety and efficacy of high-dose, posttransplantation cyclophosphamide (Cy) to prevent graft rejection and graft-versus-host disease (GVHD) after outpatient nonmyeloablative conditioning and T cell-replete bone marrow transplantation from partially HLA-mismatched (haploidentical) re...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2633246/ https://ncbi.nlm.nih.gov/pubmed/18489989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.03.005 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|